Skip to content
mRCC Tool
Toggle Navigation
1 Introduction to RCC
1.1 Introduction
1.2 Risk Factors
1.3 Pathology
1.4 The spread of RCC
1.5 Anatomical Staging of RCC
1.6 Pathophysiology
2 Symptoms and diagnosis
2.1 Symptoms of kidney cancer
2.2 Investigation of suspected kidney cancer
2.3 Multidisciplinary Team (MDT) Conference
2.4 Prognostic stratification tools for patients with mRCC
2.5 Prognostic factors
3 Management of mRCC
3.1 Treatment algorithm
3.2 Treatment criteria for initiation of TKI
3.3 Treatment criteria for initiation of checkpoint inhibitors
3.4 Response evaluation
3.5 Malignant hypercalcaemia
3.6 Performance status
4 Treatment
4.1 Treatment options for metastatic renal cell carcinoma (mRCC)
4.2 Oncology treatment: Targeted therapy
4.3 Oncology treatment: Immunotherapy
4.4 Radiation therapy
4.5 Supportive treatment
5 Toxicity management
5.1 Adverse reactions to targeted treatment
5.2 Management of TKI side effects
5.2.1 Diarrhoea management
5.2.2 Managing hypertension
5.2.3 Fatigue management
5.2.4 Management of hand and/or foot symptoms (palmar-plantar erythrodyesthesia syndrome (PPE))
5.2.5 Managing nausea/loss of appetite
5.2.6 Management of stomatitis
5.2.7 Hypothyroidism
5.2.8 Management of haematological toxicity
5.2.9 Managing liver toxicity
5.2.10 Managing proteinuria
5.3 Adverse reactions to checkpoint inhibitors
5.4 Interactions between medicinal products
Frequently asked questions (FAQs)
About mRCC Tool EN
Reference list
Back to Main Menu
1 Introduction to RCC
Radix
2024-03-28T16:53:14+00:00
Search for:
Introduction to Renal Cell Carcinoma (RCC)
Explore this chapter menu
1.1 Introduction
1.2 Risk factors
1.3 Pathology
1.4 The spread of RCC
1.5 Anatomical Staging of RCC
1.6 Pathophysiology
Page load link